INTELLIGENT BIO SOLUTIONS INC. Increase Decrease In Operating Lease Liability
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase Decrease In Operating Lease Liability of -$191.72 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$29.26K.
- INTELLIGENT BIO SOLUTIONS INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$63.16K.
- INTELLIGENT BIO SOLUTIONS INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$41.42K, a 189.74% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$57.89K.
- INTELLIGENT BIO SOLUTIONS INC. increase decrease in operating lease liability for fiscal 2026 was -$191.72K.
- INTELLIGENT BIO SOLUTIONS INC. increase decrease in operating lease liability for fiscal 2025 was -$271.50K, a 628.34% decline from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. increase decrease in operating lease liability for fiscal 2024 was $51.39K.
- INTELLIGENT BIO SOLUTIONS INC. increase decrease in operating lease liability for fiscal 2023 was -$107.92K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$29.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$92.42K derived: sum of 2 quarters · filed 2026-08-19 | -$133.84K derived: sum of 3 quarters · filed 2026-08-19 | -$191.72K 10-K · filed 2026-08-19 |
| 2026-03-31 | -$63.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$104.58K derived: sum of 2 quarters · filed 2026-05-13 | -$162.46K 10-Q · filed 2026-05-13 | -$232.83K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | -$41.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$99.30K 10-Q · filed 2026-02-12 | -$169.67K derived: sum of 3 quarters · filed 2026-08-19 | -$370.47K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | -$57.89K 10-Q · filed 2025-11-12 | -$128.25K derived: sum of 2 quarters · filed 2026-08-19 | -$329.05K derived: sum of 3 quarters · filed 2026-08-19 | -$282.90K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | -$70.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$271.17K derived: sum of 2 quarters · filed 2026-08-19 | -$225.02K derived: sum of 3 quarters · filed 2026-08-19 | -$271.50K 10-K · filed 2026-08-19 |
| 2025-03-31 | -$200.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$154.65K derived: sum of 2 quarters · filed 2026-05-13 | -$201.13K 10-Q · filed 2026-05-13 | $15.33K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $46.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$332.00 10-Q · filed 2026-02-12 | $216.13K derived: sum of 3 quarters · filed 2026-02-12 | $151.21K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | -$46.48K 10-Q · filed 2025-11-12 | $169.98K derived: sum of 2 quarters · filed 2025-11-12 | $105.06K derived: sum of 3 quarters · filed 2025-11-12 | $73.08K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $216.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $151.54K derived: sum of 2 quarters · filed 2025-08-15 | $119.56K derived: sum of 3 quarters · filed 2025-08-15 | $51.39K 10-K · filed 2025-08-15 |
| 2024-03-31 | -$64.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | -$96.90K derived: sum of 2 quarters · filed 2025-05-13 | -$165.07K 10-Q · filed 2025-05-13 | |
| 2023-12-31 | -$31.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$100.15K 10-Q · filed 2025-02-13 | ||
| 2023-09-30 | -$68.17K 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | -$107.92K 10-K · filed 2024-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |